3/19
08:09 am
lptx
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Low
Report
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
3/19
07:08 am
lptx
Rating for LPTX
Medium
Report
Rating for LPTX
3/19
07:08 am
lptx
Rating for LPTX
Medium
Report
Rating for LPTX